20 teams advance in $101 million race to extend healthy ageing
XPRIZE - 11-Aug-2026Finalists will test therapies designed to preserve muscle, brain and immune health
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Finalists will test therapies designed to preserve muscle, brain and immune health
The aim is to make better choices early, before spending years developing a new medicine
Bill Ackman is backing a major centre for neuroscience and brain health
Technology combines health scans and data to spot potential health risks before symptoms appear
Scientists are testing a longevity gene linked to healthy ageing
A major new investment will help the anti-ageing biotech test whether old cells can be partly reset to treat age-related illness
Pandorum Technologies secures new funding to develop “programmable” treatments that could repair damaged eyes and other organs
Why the organisation is cutting jobs to focus on using artificial intelligence to tackle disease
Merge Labs is developing a non-invasive brain-computer interface
Biobeat secures $50 million to expand its cuffless technology
UK biotech aims to bring eye therapy from the operating theatre to the clinic
New funding gives the regenerative biotech breathing space to prioritise placental cell therapies
New funding backs glycan biomarkers to help doctors track inflammation and biological age
Combining repair therapies in mice could redefine how science tackles aging itself
Fresh funding backs DNA origami nanobots aimed at safer, more precise gene therapies
OpenAI-backed Chai raises $130M to accelerate drug and antibody design with AI
A “lab-in-a-loop” platform could speed longevity drug discovery by learning from every experiment
Subsense advances non-surgical BCI tech with new $10M to speed preclinical research
Robotics pioneer Fred Moll backs AI-powered machines to expand access to complex surgery worldwide
siRNA therapy JUN_01 aims to reset metabolic tissues and improve long-term metabolic health
Startup bets on plasma exchange to tackle microplastics, toxins, and chronic inflammation
Blood-based circRNA signatures aim to spot Alzheimer’s risk years before symptoms appear
The teams aim to create an mRNA therapy that breaks down toxic cholesterol inside artery cells
The goal is to prepare CLG-001 for a Phase I clinical trial in the US
Targeted epigenetic editing could deliver durable, precise therapies for aging-related diseases